about
Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humansExpected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trial.Loss of methylation at GNAS exon A/B is associated with increased intrauterine growthPaternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development.Vitamin D-Dependent Rickets Type 1B (25-Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?Seasonal expression of KiSS-1 and the pituitary gonadotropins LHβ and FSHβ in adult male Libyan jird (Meriones libycus).A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute plA new FSHbeta mutation in a 29-year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH.The expression of aromatase in gonadotropes is regulated by estradiol and gonadotropin-releasing hormone in a manner that differs from the regulation of luteinizing hormone.FSHbeta gene mutation in a female with delayed puberty and hypogonadism: response to recombinant human FSH.An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial.Identification of I1171N resistance mutation in ALK-positive non-small-cell lung cancer tumor sample and circulating tumor DNA.CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status fHigh frequency of paternal iso or heterodisomy at chromosome 20 associated with sporadic pseudohypoparathyroidism 1BMolecular characterization of a recurrent 10.9 kb CYP24A1 deletion in Idiopathic Infantile Hypercalcemia[New biological treatments for lung cancer]Array CGH analysis in high-risk pregnancies: comparing DNA from cultured cells and cell-free fetal DNAIdentification by array-Comparative Genomic Hybridization (array-CGH) of a large deletion of luteinizing hormone receptor gene combined with a missense mutation in a patient diagnosed with a 46,XY disorder of sex development and application to prena[Epigenetics and pseudohypoparathyroidism]Diagnosis and management of congenital hypothyroidism associated with pseudohypoparathyroidismDe novo 15q13.3 microdeletion with cryptogenic West syndromeDisruptive mutations in TANC2 define a neurodevelopmental syndrome associated with psychiatric disordersClinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2)Maternal Transmission Ratio Distortion of GNAS Loss-of-Function MutationsRelevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice
P50
Q28280832-F41F3EB7-6200-496F-9D08-6F8F1B4473A8Q33403609-9A492E30-18D0-47F0-9DFB-70C45C0239B7Q35442006-16B13D04-BA0F-407A-A5A9-DE10BFAAC7D0Q37149603-0673A185-6B46-455C-B4D7-0C9B604C0353Q38761734-4FCDF3BF-90F1-4758-85A7-D4037F420DC4Q38916815-F6B0B0EC-9799-451E-8477-A6CCE3E04AA1Q39067796-C122DDC2-B0BC-4CF0-B3BE-60C4692D07A8Q39766338-BD13CEAC-59EC-4DD5-B32E-7B9530B28ED5Q40269757-00F7C892-0B73-48E3-80A9-FD47492AF0E5Q43196277-59A03508-4208-4626-80EB-C31292F808D0Q50585675-BA43EFCD-B443-46FF-AE11-8FE1A1D47239Q51548102-EC0ED917-3AFB-439C-9F03-D7716CB93905Q54587266-00111013-499F-401F-8380-F36F5971CEB4Q57419586-4B18CEC9-C6F7-4137-B167-1E86C2129F60Q64039725-97700001-B893-4273-8430-27708C1B0E38Q64042734-F7286E36-0617-4F72-9BDA-3B42ECFD8A85Q80212282-B8C0EF85-CBDF-4383-BAB1-1CD4AE438F7CQ82183820-8E15AAD0-E107-44BF-A4DA-35E72B146BC5Q84482452-CBD169EF-4AC0-407E-9E59-1E69B24E040FQ84958201-52941666-6ADE-460F-8234-613691C19D8CQ86538571-F144170F-D765-43A9-B164-2A5C7727EAE7Q87225692-E953CD09-44B4-46D1-9BA9-4ABA86114E7CQ90730812-0AA3D8B6-FA1D-46AE-833C-BCEF5D394859Q91208912-0A2E8946-B954-4699-98B0-DCC2BB1880A5Q92319000-C526E4A8-59E0-4AFB-A386-35920670D985Q92416792-40BE97F9-4183-4E28-AA31-414804EA4A94
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicolas Richard
@ast
Nicolas Richard
@en
Nicolas Richard
@es
Nicolas Richard
@nl
type
label
Nicolas Richard
@ast
Nicolas Richard
@en
Nicolas Richard
@es
Nicolas Richard
@nl
prefLabel
Nicolas Richard
@ast
Nicolas Richard
@en
Nicolas Richard
@es
Nicolas Richard
@nl
P106
P1153
16231189800
P21
P31
P496
0000-0003-0702-7399